Novo Nordisk

Ultime notizie

Titoli nella lingua originale della fonte.

• 
  Stocktwits Biotech Dealmaker — Novartis, Sanofi And Novo Sign Week’s Biggest Deals (si apre in una nuova scheda)

  3 ott 2026

• 
  Novo Nordisk Holds Its 2026 Outlook As FDA Review Of Its Blood Disorder Drug Runs Long (si apre in una nuova scheda)

  2 ott 2026

• 
  Anthropic Is Spending $100M To Build The AI Workforce It Needs For Its Next Phase (si apre in una nuova scheda)

  2 ott 2026

• US FDA extends review of Novo Nordisk's hemophilia drug over facility issues (si apre in una nuova scheda)

  Reuters · 2 ott 2026

• FDA extends review for Novo Nordisk's denecimig for hemophilia A (si apre in una nuova scheda)

  TradingView · 2 ott 2026

• eli lilly and novo nordisk will discount their weight-loss drugs (si apre in una nuova scheda)

  BusinessWorld Online · 2 ott 2026

• Novo provides update on the denecimig Biologics License Application (BLA) in the US (si apre in una nuova scheda)

  Yahoo Finance UK · 2 ott 2026

• eli lilly and novo nordisk weight loss drugs (si apre in una nuova scheda)

  BusinessWorld Online · 2 ott 2026

• novo nordisk glp 1 drugs for weight loss (si apre in una nuova scheda)

  BusinessWorld Online · 2 ott 2026

• Novo Nordisk Strikes Nearly $4 Billion in 2 Deals. Here's What That Means for Investors (si apre in una nuova scheda)

  2 ott 2026

• weight loss drug novo nordisk (si apre in una nuova scheda)

  BusinessWorld Online · 2 ott 2026

• novo nordisk cuts cash prices for weight-loss drugs. (si apre in una nuova scheda)

  BusinessWorld Online · 2 ott 2026

• novo nordisk drug study shows significant weight loss results (si apre in una nuova scheda)

  BusinessWorld Online · 2 ott 2026

• novo nordisk weight loss drug news (si apre in una nuova scheda)

  BusinessWorld Online · 2 ott 2026

• Novo Nordisk's Semaglutide Edges Out Tirzepatide on Heart Risk as Oral Wegovy Sheds Pounds in Real-W (si apre in una nuova scheda)

  AD HOC NEWS · 2 ott 2026

• Novo Nordisk vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? (si apre in una nuova scheda)

  The Motley Fool · 2 ott 2026

• novo nordisk is cutting prices on its weight loss drugs (si apre in una nuova scheda)

  BusinessWorld Online · 2 ott 2026

• Novo Nordisk Tests Zenagamtide Dosing to Sharpen Its Obesity Drug Pipeline (si apre in una nuova scheda)

  TipRanks · 2 ott 2026

• Novo Nordisk (NYSE: NVO) Wegovy Clears Liver Fat To Normal Levels In Nearly 9 Out Of 10 Obese Adults In STEP UP Trial Analysis (si apre in una nuova scheda)

  foreignpolicyjournal.com · 2 ott 2026

• Novo Nordisk (CPSE:NOVO B) On New Wegovy Data And The Valuation Narrative (si apre in una nuova scheda)

  Yahoo Finance · 2 ott 2026

• novo nordisk says obesity drug trial confirms weight loss (si apre in una nuova scheda)

  BusinessWorld Online · 2 ott 2026

• novo nordisks new drug amycretin shows significant weight loss (si apre in una nuova scheda)

  BusinessWorld Online · 2 ott 2026

• Novo Nordisk's Dual Data Drop: CagriSema Outperforms Tirzepatide as Oral Wegovy Holds Its Own (si apre in una nuova scheda)

  AD HOC NEWS · 2 ott 2026

• novo nordisk sues hims & hers over copycat weight-loss drugs (si apre in una nuova scheda)

  BusinessWorld Online · 2 ott 2026

• DXCM Report Highlights CGM Growth Opportunity in Type 2 Diabetes Care (si apre in una nuova scheda)

  2 ott 2026

• novo nordisk weight loss drug wegovy approved in china (si apre in una nuova scheda)

  BusinessWorld Online · 2 ott 2026

• Agios' Growth Story Hinges on Mitapivat's Commercial Expansion (si apre in una nuova scheda)

  2 ott 2026

• Prediction: Eli Lilly Could Be the Next $2 Trillion Drugmaker (si apre in una nuova scheda)

  2 ott 2026

• 3 drug targets pharma is betting on next (si apre in una nuova scheda)

  2 ott 2026

• Novo Nordisk's Wegovy Pill Cuts Liver Fat in 88.5% of Patients as Shares Stay Stuck Near Yearly Lows (si apre in una nuova scheda)

  AD HOC NEWS · 2 ott 2026